The effect of velnacrine on the mixed function oxidase system

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 22, Issue 2, 1997, Pages 121-125

  Eccles, M J ^a   Danbury, T C ^a   Ford, J M ^a   Roberts, C J C ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Drug interactions; Mixed function oxidase; Velnacrine

Indexed keywords

3 HYDROXYMETHYLPHENAZONE; 4 HYDROXYPHENAZONE; CHOLINESTERASE INHIBITOR; CIMETIDINE; LIVER ENZYME; MIXED FUNCTION OXIDASE; NORPHENAZONE; OXIDOREDUCTASE; PHENAZONE; VELNACRINE;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; LIVER MICROSOME; MALE; NONHUMAN; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0030833801     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03189794     Document Type: Article

References (22)

1. Arendt T., Bigl V., Arendt A., Tennstedt A. (1983) : Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease. Acta Neuropathol., 61, 101-108.
2. Candy J.M., Perry E.K. (1983) : Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases. J. Neurol. Sci., 59, 277-289.
3. Rogers J.D., Brogan D., Mirra S.S. (1985) : The nucleus basalis of Meynert in neurological disease: A quantitative morphological study. Ann. Neurol., 17, 163-170.
4. Whitehouse P.J., Price D.L., Struble R.G. (1986) : Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science, 215, 1237-1239.
5. Johns C.A., Haroutunian V., Greenwald B.S. (1985) : Development of cholinergic drugs for the treatment of Alzheimer's disease. Drug. Dev. Res., 5, 77-96.
6. Murphy F.M., Hardiman S.T., Nash R.J., et al. (1991) : Evaluation of HP029 (velnacrine maleate) in Alzheimer's disease. Ann. NY Acad. Sci., 640, 253-262.
7. Knapp M.J., Knopman D.S., Solomon P.R., Pendlebury W.W., Davis C.S., Gracon S.I. (1994) : A 30-week randomised controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA, 271, 985-991.
8. Spaldin V., Madden S., Pool W.F., Woolf T.F., Park B.K. (1994) : The effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomes. Br. J. Clin. Pharmacol., 38, 15-22.
9. Sharer J.E., Wrighton S.A. (1996) : Identification of the human hepatic cytochromes P450 involved in the in vitro oxidation of antipyrine Drug Metab. Dispos., 24, 487-494.
10. Breimer D.D. (1983) : Interindividual variations in drug disposition. Clinical implications and methods of investigation. Clin. Pharmacokinet., 8, 371-377.
11. Boobis A.R., Sesardic D., Murray B.P., et al. (1990) : Species variation in the response of the cytochrome P-450-dependent monooxygenase system to inducers and inhibitors. Xenobiotica, 20, 1139-1161.
12. Inaba T., Lucassen M., Kalow W. (1980) : Antipyrine metabolism in the rat by three hepatic monooxygenases. Life. Sci., 26, 1977-1983.
13. Rhodes J.C., Hall S.T., Houston J.B. (1984) : Inhibition of antipyrine metabolite formation in rats in vivo. Xenobiotica, 14, 677-686.
14. Somogyi A., Gugler R. (1982) : Drug interactions with cimetidine. Clin. Pharmacokinet., 7, 23-41.
15. Pelkonen O., Puurunen J. (1980) : The effect of cimetidine on in vitro and in vivo microsomal drug metabolism in the rat. Biochem. Pharmacol., 29, 3075-3080.
16. Knodell R.G., Holtzmann J.L., Crankshaw D.L. (1982) Drug metabolism by rat and human hepatic microsomes in response to interactions with histamine H2 antagonists. Gastroenterology, 82, 84-88.
17. Sorkin E.M., Darvey D.L. (1983) : Review of cimetidine drug interactions. Drug Intell. Clin. Pharm., 17, 110-120
18. Powell J.R., Donn K.H. (1983) : The pharmacokinetic basis for histamine H2 antagonist drug interactions. Concepts and implications. J. Clin. Gastroenterol., 5, 95-113.
19. Bast A., Savenije-Chapel E.M., Kroes B.H. (1984) Inhibition of mono-oxygenase and oxidase activity of rat hepatic cytochrome P450 by histamine H2 blockers. Xenobiotica, 14, 399-408
20. Jensen J.C., Gugler R. (1985) : Cimetidine interaction with liver microsomes in vitro and in vivo. Involvement of an activated complex with cytochrome P450. Biochem: Pharmacol., 34, 2141-2146.
21. Rekka E., Sterk G.J., Timmerman H., Bast, A. (1988) : Identification of structural characteristics of some potential histamine H2 antagonists that determine the interaction with rat hepatic P450. Chem. Biol. Interact., 67, 117-127.
22. Faux S.P., Combes R.D. (1993) : Interaction of cimetidine with cytochrome P450 and effect on mixed function oxidase activities of liver microsomes. Hum. Exp. Toxicol., 12, 147-152.